We may earn a commission if you sign up or buy through links on this page. This doesn’t affect our rankings, which follow our methodology.
The cheapest GLP-1 without insurance, as of November 2026, is an FDA-approved pill: the Wegovy® pill and Foundayo™ both start at $149 a month self-pay, rising to $299 at higher doses. Brand-name weekly injections start at $199 to $299. Compounded versions can cost less, but they are not FDA-approved, and the FDA has raised safety concerns about them.
Those prices come from the manufacturers’ own pharmacies, NovoCare and LillyDirect, checked November 14, 2026. Below, we rank every legitimate cash route, add the prescriber fee most guides leave out, and show what a full year really costs.
Key takeaways in 30 seconds
- Cheapest FDA-approved option: a GLP-1 pill at $149 a month, but $299 a month at higher doses.
- The pharmacy price excludes the prescription. A telehealth membership adds about $49 to $129 a month.
- At the $299 tier, a year on a brand-name pill costs about $3,300 to $4,200, depending on your first months’ price and the prescriber.
- Compounded GLP-1s often advertise lower prices, but they are not FDA-approved: the FDA does not review them for safety, effectiveness or quality, and says to use them only when an approved drug can’t meet your medical needs.
Contents
What is the cheapest GLP-1 without insurance right now?
The two GLP-1 pills approved for weight management, the Wegovy pill and Foundayo, tie for the lowest starting cash price: $149 a month. The cheapest brand-name injection is the Wegovy pen at $199 for two introductory fills, then $349.
Cash prices on the manufacturers’ pharmacies, as of November 14, 2026 (prescription required)
| Rank | Medication | FDA status for weight | Official seller | Lowest published price | Higher doses / after intro | Self-pay page |
|---|---|---|---|---|---|---|
| 1 (tie) | Wegovy® pill (semaglutide) | Approved for weight | NovoCare Pharmacy | $149 (1.5 mg) | $199 (4 mg) · $299 (9 and 25 mg) | See pricing |
| 1 (tie) | Foundayo™ (orforglipron) | Approved for weight | LillyDirect | $149 (0.8 mg; 2.5 mg until Dec 31, 2026) | $199 (5.5 mg, until Dec 31, 2026) · $299 (9, 14.5, 17.2 mg) | See pricing |
| 3 | Wegovy® pen (semaglutide) | Approved for weight | NovoCare Pharmacy | $199 for 2 intro fills (0.25 / 0.5 mg, new patients, until Dec 31, 2026) | $349 (0.25 to 2.4 mg) · $399 (HD 7.2 mg) | See pricing |
| 4 | Zepbound® KwikPen or vial (tirzepatide) | Approved for weight | LillyDirect | $299 (2.5 mg) | $399 (5 mg) · $449 (7.5 to 15 mg, refill within 45 days) | See pricing |
| — | Ozempic® tablets (semaglutide) | Type 2 diabetes only (weight use is off-label) | NovoCare Pharmacy | $149 (lowest strength) | $199 · $299, by strength | — |
| — | Ozempic® pen (semaglutide) | Type 2 diabetes only | NovoCare Pharmacy | $199 for 2 intro fills | $349 (0.25 to 1 mg) · $499 (2 mg) | — |
| — | Mounjaro® (tirzepatide) | Type 2 diabetes only | LillyDirect | Starting at $499 (every strength) | No separate price published | — |
| — | Compounded semaglutide / tirzepatide | Not FDA-approved | Telehealth programs | “As low as” $60 / $90 plus membership | Price rises by dose | — |
Doses appear only because the price changes with the package strength. Your prescriber decides which medication and dose, if any, fit you.
Two things the headline prices hide: the $149 tier covers only the lowest strengths, and the pharmacy price excludes the prescriber (see below). The compounded row is a different product, not a cheaper copy (details).
On Medicare? Manufacturer savings offers exclude government beneficiaries. Eligible people with Medicare drug coverage may pay $50 a month instead: see the $50 Medicare GLP-1 Bridge.
Which FDA-approved GLP-1s cost the least with cash, and what does a “month” buy?
Pills are the cheapest GLP-1 brand-name option at every self-pay tier in the table above. What differs between products is what a “month” contains, what you buy on the side and which use the FDA approved.
GLP-1 pills: Wegovy pill and Foundayo
On NovoCare, one month of the Wegovy pill is “1 bottle of 30 tablets”. On LillyDirect, a Foundayo month “is defined as 30-days”. Nothing else to buy: no needles or syringes.
Foundayo’s cheapest strengths carry a temporary price, and its top strengths a refill condition (see the pricing traps). For food rules and trial results, read how the two GLP-1 pills differ beyond price.
Weekly injections: Wegovy pen and Zepbound
A Wegovy month is “1 box of 4 pens”, one per week, so it lasts 28 days. The $199 intro covers only 2 fills of the lowest strengths for people new to NovoCare’s offer.
For self-pay, LillyDirect defines a Zepbound month as 28 days: 1 KwikPen or 4 single-dose vials. It adds a cost the table doesn’t show: KwikPen buyers must purchase pen needles, and vial buyers must purchase needles and syringes. The vial is sold only through LillyDirect, for self-pay.
Both injections are approved for chronic weight management in adults who meet the label’s BMI criteria (the Wegovy injection also in some teens 12 and older; see the Wegovy prescribing information). You can check whether you meet the label’s BMI criteria before talking to your doctor.
Ozempic and Mounjaro: not approved for weight
Ozempic (NovoCare) and Mounjaro (LillyDirect) are sold self-pay too, but the FDA approved them for type 2 diabetes, not for weight loss. Prescribing them for weight is off-label.
Mounjaro has the highest starting cash price in our ranking: LillyDirect lists every strength at “starting at $499/month.” The tirzepatide product the FDA approved for weight management is Zepbound; your prescriber decides which medication is appropriate.
Safety first: what the labels say
Price is only one part of the decision. These points come from the Wegovy, Foundayo and Zepbound labels; Ozempic and Mounjaro carry the same thyroid warning.
- Don’t use them if you or a family member have had medullary thyroid cancer (MTC), if you have MEN 2, a rare inherited syndrome (boxed warning), or if you’ve had a serious allergic reaction to the drug.
- Pregnancy: the labels warn of possible risk to the fetus and say to stop the drug when pregnancy is recognized; Wegovy’s label says to stop it at least 2 months before a planned pregnancy. If you’re pregnant, planning a pregnancy or breastfeeding, talk to your clinician first. Zepbound can make birth-control pills less effective for 4 weeks after starting and after each dose increase; ask your clinician about a non-oral or backup method.
- Under 18: the pills and Zepbound are approved for adults only; the Wegovy injection is also approved for some teens 12 and older, under a pediatric prescriber.
- Common side effects: nausea, diarrhea, vomiting, constipation and stomach pain, most often when the dose goes up. Vomiting or diarrhea can cause dehydration and kidney injury; call your clinician if you can’t keep fluids down.
- Tell your clinician first if you’ve had pancreatitis, gallbladder disease, kidney problems, severe gastroparesis, diabetic eye disease or an eating disorder, or if you take insulin or a sulfonylurea (risk of low blood sugar). Don’t combine two GLP-1s, brand-name or compounded.
- Never share an injection pen with anyone, even with a new needle.
Can you get a GLP-1 without insurance or a membership? What the prescriber adds
Yes: NovoCare and LillyDirect charge no membership, but both require a prescription. That prescription has to come from somewhere, and its cost is the line most price lists leave out.
You have two options:
- Your own clinician. The visit cost depends on your clinic and is not published, so we don’t estimate it.
- A telehealth program. It prescribes the drug, and you pay a monthly membership on top of the manufacturer’s price.
Cheapest published memberships for brand-name GLP-1s (medication not included), as of November 13, 2026
| Program | Monthly price | Cheaper with a commitment |
|---|---|---|
| Mochi Health | $79 (first month free for new members, not all states) | $49 a month on a 12-month plan ($588); labs extra |
| Sesame | $99 month to month | “As low as $59” a month on an annual plan |
| Ivím Health | $75 (first month free) | — |
| WeightWatchers Med+ | $74 a month on a 12-month plan | Plan auto-renews for another 12 months at the same rate |
| Noom (telehealth for branded medication) | $39 to start, then $129, billed quarterly | — |
We couldn’t check Ro, Hims & Hers or Eden prices: their sites block automated checks, and prices may only appear after an online assessment.
So the real monthly floor for a brand-name pill at the starter price is about $198 ($149 plus Mochi’s $49 annual rate) to $228 ($149 plus a $79 monthly membership). For every program’s fees and what each covers, see all 15 programs and what each fee covers, and how we check prices.
Compounded semaglutide and tirzepatide: why they’re cheaper, and what you give up
Compounded GLP-1s often have the lowest cash price because a pharmacy mixes them outside the FDA approval process. Compounded semaglutide is a version of the active ingredient prepared by a compounding pharmacy, not the FDA-approved Wegovy or Ozempic; the same applies to compounded tirzepatide and Zepbound or Mounjaro.
The FDA’s page on unapproved GLP-1 drugs (checked November 14, 2026) states:
- Compounded drugs are not FDA-approved, and the agency does not review them for safety, effectiveness or quality before they are marketed.
- They should only be used in patients whose medical needs cannot be met by an FDA-approved drug.
- Salt forms (semaglutide sodium, semaglutide acetate) are different active ingredients from the one in approved products.
- As of May 31, 2026, the FDA had received 990 adverse-event reports for compounded semaglutide and more than 730 for compounded tirzepatide, and says these are likely underreported. It also received reports of dosing errors with compounded injectable semaglutide, some requiring hospitalization.
- The FDA declared the national shortages of tirzepatide injection (December 19, 2024) and semaglutide injection (February 21, 2025) resolved.
With both shortages over, the FDA’s position is that compounded versions are for patients whose medical needs an approved drug can’t meet. That is a medical decision for your clinician, not a pricing one. The FDA also warns about fraudulent compounded semaglutide and tirzepatide with false pharmacy labels, and advises filling any prescription at a state-licensed pharmacy. Red flags it lists: a seller that doesn’t require a screening and prescription by a licensed doctor, or medicine that looks different from what you received before or arrives without instructions for use.
What the evidence says. Wegovy (pill and pen), Foundayo and Zepbound: strong evidence, from large randomized trials reviewed by the FDA for chronic weight management. Ozempic and Mounjaro: tested and approved for type 2 diabetes; weight use is off-label. Compounded semaglutide and tirzepatide: no direct evidence. The trials tested the approved products, not compounded versions, whose content and quality the FDA has not checked.
Published compounded prices (alphabetical, not a ranking), as of November 13, 2026
| Program | Published price | What’s included |
|---|---|---|
| Found | $149 per 28-day cycle on a 12-month prepaid cash plan; $269 on the monthly plan | Medication included |
| Henry Meds | $297 a month (semaglutide); $2,364 for 12 months paid in full | Medication and injection kit |
| MEDVi | $99 first month, then $199 (semaglutide) | Medication included |
| Mochi Health | “As low as” $60 (semaglutide) or $90 (tirzepatide), by dose | Plus $49 to $79 membership |
| Remedy Meds | $179 then $299 (semaglutide); $279 then $399 (tirzepatide) | Prescription and delivery included |
Compounded “GLP-1 pills,” drops or “microdose” plans are not the Wegovy pill or Foundayo. Some telehealth programs now sell compounded semaglutide tablets and even “compounded orforglipron,” the active ingredient in Foundayo, sometimes for less than the $149 brand-name price. They are not FDA-approved, the FDA has not reviewed their safety, effectiveness or quality, and we found no published clinical trial that tested compounded oral, under-the-tongue or microdose GLP-1 products. A lower price is not a reason to choose one: ask your doctor about the FDA-approved options first.
We don’t link to compounded sellers, and we don’t rank them.
What does a year on the cheapest GLP-1 really cost? Our 12-month math
A “$149” GLP-1 pill costs about $3,300 to $3,600 a year in medication alone once the $299 tier applies, and about $3,900 to $4,200 with the cheapest published membership. Brand injections run about $4,200 to $5,800 a year in medication alone.
What a year costs at November 2026 prices (medication, plus the cheapest published membership)
| Route | Year at the steady price | + $588 membership (Mochi, 12-month plan) | First-year example |
|---|---|---|---|
| Wegovy® pill or Foundayo™ at $299 | $3,588 (12 × $299) | $4,176 | $3,338 if the first two months cost $149 and $199 (149 + 199 + 10 × 299) |
| Wegovy® pen at $349 | $4,537 (13 × $349) | $5,125 | $4,237 with the 2 intro fills (2 × 199 + 11 × 349) |
| Zepbound® at $449 (on-time refills) | $5,837 (13 × $449) | $6,425 | $5,637 (299 + 399 + 11 × 449) |
| Zepbound® at $699 (late refills, 10-15 mg) | $9,087 (13 × $699) | $9,675 | — |
We don’t calculate a year on compounded products. They are not FDA-approved, their advertised prices apply to starting doses and change by dose and program, and the FDA’s safety concerns (see above) matter more than the price.
How we calculated this. Prices from the official pages listed above, held constant for 12 months. Pills: 12 fills of 30 tablets or 30 days, which covers 360 days; a full 365 days would add about 5 days of pills (about $50 at $299 a month). Pens and vials: 13 fills, because a box of 4 weekly pens and LillyDirect’s “month” both last 28 days. The membership is the cheapest published 12-month plan; your own doctor may cost more or less. The rows are price tiers, not dosing recommendations: your clinician decides the dose.
Prices can change at any time. The biggest swing is the Zepbound refill rule: late refills at the top strengths add $3,250 a year. To run your own numbers, plug your own quotes into our GLP-1 cost calculator, and talk to your doctor about which medication is appropriate before comparing prices.
Do discount cards, Costco, TrumpRx or an HSA lower the price further?
Usually not below the manufacturer’s self-pay price. Without insurance, that self-pay price already is the discount.
Manufacturer savings cards (“as low as $25”). These are for people whose commercial insurance covers the drug. NovoCare caps savings at $100 a month, and both NovoCare and LillyDirect exclude government beneficiaries. If you’re uninsured, they don’t apply.
TrumpRx.gov. On November 14, 2026, TrumpRx.gov listed the Wegovy pill at $149 a month, the Wegovy pen at $199, Ozempic (approved for type 2 diabetes only) at $199 and Zepbound at $299, against “original” prices of $1,349, $1,349, $1,028 and $1,087. These match the lowest or intro self-pay prices in our table: no extra discount.
Costco. Costco Pharmacy has a Member Value Pricing page for Wegovy. It says the program is not insurance and that claims under Medicare, Medicaid or private insurance aren’t eligible. Our tools couldn’t read the price, so check the current price on Costco’s Wegovy pricing page or at your Costco pharmacy.
Pharmacy discount cards. We couldn’t verify any card price; compare any you find with the manufacturer price above.
HSA or FSA. LillyDirect lists its GLP-1s as “FSA/HSA eligible” (“eligibility may vary by plan”), and NovoCare accepts FSA and HSA cards. Paying with pre-tax money lowers your real cost; how much depends on your tax bracket.
Near me. LillyDirect offers free delivery or pickup, and NovoCare offers home delivery or pickup.
5 pricing traps that turn the cheapest offer into an expensive one
The lowest advertised self-pay price is often temporary, conditional or billed differently than it looks. Here are five traps, each dated.
- Intro fills expire. The $199 Wegovy and Ozempic pen price covers 2 fills for new patients, through December 31, 2026.
- Temporary price cuts. Foundayo’s 2.5 mg and 5.5 mg prices are reduced only through December 31, 2026, and LillyDirect doesn’t publish the price after that.
- The 45-day refill rule. Zepbound 7.5 mg to 15 mg costs $449 only if you refill within 45 days; otherwise $499 (7.5 mg) or $699 (10 mg to 15 mg). Foundayo’s two top strengths have the same condition.
- Commitments and auto-renewal. The WeightWatchers 12-month plan renews automatically at the same rate. Calibrate requires a 3-month commitment ($597). Found and Henry Meds (compounded, not FDA-approved) offer their lowest rates only when you prepay.
- A “month” isn’t always a month. A 28-day supply means 13 fills a year, not 12. Noom bills quarterly, so you pay 3 months at once after the intro.
Don’t change how you take your medication to save money, and if your prescriber pauses or lowers your dose, follow that even if the price changes.
What to read next
- Weight-loss program prices: compare 15 programs line by line, fees included.
- GLP-1 cost calculator: your own 12-month total from your quotes.
- Foundayo vs Wegovy pill: choosing between the two $149 pills.
- Medicare GLP-1 Bridge: if you have Medicare.
Frequently asked questions
Can you get the cheapest GLP-1 without insurance or a prescription?
No. There is no legitimate way to get a GLP-1 without a prescription in the US: LillyDirect and NovoCare both require one, and the FDA has sent warning letters to sellers of illegally marketed semaglutide and tirzepatide.
The FDA also says retatrutide and cagrilintide cannot be used in compounding under federal law. Sellers offering GLP-1s without a prescription, or peptides labeled “for research use only,” are not a safe shortcut.
Will GLP-1 cost come down?
We don’t forecast prices. What we can say: several current prices are temporary, including Foundayo’s reduced 2.5 mg and 5.5 mg prices and NovoCare’s $199 intro fills, which both end December 31, 2026. We re-check prices every month in the tracker we update monthly.
Does Medicare cover GLP-1s for weight loss?
Through a temporary program, yes for some people. The Medicare GLP-1 Bridge lets eligible people with Medicare drug coverage get Foundayo, Wegovy or Zepbound KwikPen for a $50 copay per one-month supply, from July 1, 2026 through December 31, 2027. Eligibility depends on BMI and certain health conditions; see how the Medicare GLP-1 Bridge works.
Are the GLP-1 prices people share online real?
Some are, but many are out of date or quote an intro price as the monthly price. Check the official page before you pay. The manufacturer prices here link to their official pages, and our tracker shows the exact quote and date for each program.
Conclusion
The cheapest FDA-approved GLP-1 without insurance is a pill: $149 a month to start, $299 at higher doses, plus a prescriber. Compounded semaglutide can cost less, but it is not FDA-approved, and the FDA says to use it only when an approved drug can’t meet your medical needs. Before you compare offers, count the price at the strength you’re likely to be prescribed, add the prescriber and multiply by 12 or 13 fills. For more on cost and insurance, browse our pillar page, and talk to your clinician about which medication is right for you.
This article is for information only and does not replace advice from your healthcare provider. Talk to your doctor or pharmacist before starting, stopping or changing any medication. How we work: every price is checked on the official page on the date shown, every safety statement against the current FDA labels and FDA guidance, and we say when something could not be confirmed. Prices change; we last checked them on November 14, 2026.
